Metabolic profiling reveals distinct variations linked to nicotine consumption in humans - First results from the KORA study

Rui Wang-Sattler, Yao Yu, Kirstin Mittelstrass, Eva Lattka, Elisabeth Altmaier, Christian Gieger, Karl H. Ladwig, Norbert Dahmen, Klaus M. Weinberger, Pei Hao, Lei Liu, Yixue Li, H. Erich Wichmann, Jerzy Adamski, Karsten Suhre, Thomas Illig

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Exposure to nicotine during smoking causes a multitude of metabolic changes that are poorly understood. We quantified and analyzed 198 metabolites in 283 serum samples from the human cohort KORA (Cooperative Health Research in the Region of Augsburg). Multivariate analysis of metabolic profiles revealed that the group of smokers could be clearly differentiated from the groups of former smokers and non-smokers. Moreover, 23 lipid metabolites were identified as nicotine-dependent biomarkers. The levels of these biomarkers are all up-regulated in smokers compared to those in former and non-smokers, except for three acyl-alkyl-phosphatidylcholines (e.g. plasmalogens). Consistently significant results were further found for the ratios of plasmalogens to diacyl-phosphatidylcolines, which are reduced in smokers and regulated by the enzyme alkylglycerone phosphate synthase (alkyl-DHAP) in both ether lipid and glycerophospholipid pathways. Notably, our metabolite profiles are consistent with the strong down-regulation of the gene for alkyl-DHAP (AGPS) in smokers that has been found in a study analyzing gene expression in human lung tissues. Our data suggest that smoking is associated with plasmalogen-deficiency disorders, caused by reduced or lack of activity of the peroxisomal enzyme alkyl-DHAP. Our findings provide new insight into the pathophysiology of smoking addiction. Activation of the enzyme alkyl-DHAP by small molecules may provide novel routes for therapy.

Original languageEnglish
Article numbere3863
JournalPLoS One
Volume3
Issue number12
DOIs
Publication statusPublished - 5 Dec 2008
Externally publishedYes

Fingerprint

Plasmalogens
nicotine
metabolomics
Metabolites
Nicotine
Smoking
Biomarkers
metabolites
biomarkers
Enzymes
Glycerophospholipids
Lipids
deficiency diseases
enzyme activation
Enzyme Activation
Metabolome
lipids
pathophysiology
Phosphatidylcholines
Gene expression

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Wang-Sattler, R., Yu, Y., Mittelstrass, K., Lattka, E., Altmaier, E., Gieger, C., ... Illig, T. (2008). Metabolic profiling reveals distinct variations linked to nicotine consumption in humans - First results from the KORA study. PLoS One, 3(12), [e3863]. https://doi.org/10.1371/journal.pone.0003863

Metabolic profiling reveals distinct variations linked to nicotine consumption in humans - First results from the KORA study. / Wang-Sattler, Rui; Yu, Yao; Mittelstrass, Kirstin; Lattka, Eva; Altmaier, Elisabeth; Gieger, Christian; Ladwig, Karl H.; Dahmen, Norbert; Weinberger, Klaus M.; Hao, Pei; Liu, Lei; Li, Yixue; Wichmann, H. Erich; Adamski, Jerzy; Suhre, Karsten; Illig, Thomas.

In: PLoS One, Vol. 3, No. 12, e3863, 05.12.2008.

Research output: Contribution to journalArticle

Wang-Sattler, R, Yu, Y, Mittelstrass, K, Lattka, E, Altmaier, E, Gieger, C, Ladwig, KH, Dahmen, N, Weinberger, KM, Hao, P, Liu, L, Li, Y, Wichmann, HE, Adamski, J, Suhre, K & Illig, T 2008, 'Metabolic profiling reveals distinct variations linked to nicotine consumption in humans - First results from the KORA study', PLoS One, vol. 3, no. 12, e3863. https://doi.org/10.1371/journal.pone.0003863
Wang-Sattler, Rui ; Yu, Yao ; Mittelstrass, Kirstin ; Lattka, Eva ; Altmaier, Elisabeth ; Gieger, Christian ; Ladwig, Karl H. ; Dahmen, Norbert ; Weinberger, Klaus M. ; Hao, Pei ; Liu, Lei ; Li, Yixue ; Wichmann, H. Erich ; Adamski, Jerzy ; Suhre, Karsten ; Illig, Thomas. / Metabolic profiling reveals distinct variations linked to nicotine consumption in humans - First results from the KORA study. In: PLoS One. 2008 ; Vol. 3, No. 12.
@article{994315f4c41f4baa8372226f7d7cfd3f,
title = "Metabolic profiling reveals distinct variations linked to nicotine consumption in humans - First results from the KORA study",
abstract = "Exposure to nicotine during smoking causes a multitude of metabolic changes that are poorly understood. We quantified and analyzed 198 metabolites in 283 serum samples from the human cohort KORA (Cooperative Health Research in the Region of Augsburg). Multivariate analysis of metabolic profiles revealed that the group of smokers could be clearly differentiated from the groups of former smokers and non-smokers. Moreover, 23 lipid metabolites were identified as nicotine-dependent biomarkers. The levels of these biomarkers are all up-regulated in smokers compared to those in former and non-smokers, except for three acyl-alkyl-phosphatidylcholines (e.g. plasmalogens). Consistently significant results were further found for the ratios of plasmalogens to diacyl-phosphatidylcolines, which are reduced in smokers and regulated by the enzyme alkylglycerone phosphate synthase (alkyl-DHAP) in both ether lipid and glycerophospholipid pathways. Notably, our metabolite profiles are consistent with the strong down-regulation of the gene for alkyl-DHAP (AGPS) in smokers that has been found in a study analyzing gene expression in human lung tissues. Our data suggest that smoking is associated with plasmalogen-deficiency disorders, caused by reduced or lack of activity of the peroxisomal enzyme alkyl-DHAP. Our findings provide new insight into the pathophysiology of smoking addiction. Activation of the enzyme alkyl-DHAP by small molecules may provide novel routes for therapy.",
author = "Rui Wang-Sattler and Yao Yu and Kirstin Mittelstrass and Eva Lattka and Elisabeth Altmaier and Christian Gieger and Ladwig, {Karl H.} and Norbert Dahmen and Weinberger, {Klaus M.} and Pei Hao and Lei Liu and Yixue Li and Wichmann, {H. Erich} and Jerzy Adamski and Karsten Suhre and Thomas Illig",
year = "2008",
month = "12",
day = "5",
doi = "10.1371/journal.pone.0003863",
language = "English",
volume = "3",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

TY - JOUR

T1 - Metabolic profiling reveals distinct variations linked to nicotine consumption in humans - First results from the KORA study

AU - Wang-Sattler, Rui

AU - Yu, Yao

AU - Mittelstrass, Kirstin

AU - Lattka, Eva

AU - Altmaier, Elisabeth

AU - Gieger, Christian

AU - Ladwig, Karl H.

AU - Dahmen, Norbert

AU - Weinberger, Klaus M.

AU - Hao, Pei

AU - Liu, Lei

AU - Li, Yixue

AU - Wichmann, H. Erich

AU - Adamski, Jerzy

AU - Suhre, Karsten

AU - Illig, Thomas

PY - 2008/12/5

Y1 - 2008/12/5

N2 - Exposure to nicotine during smoking causes a multitude of metabolic changes that are poorly understood. We quantified and analyzed 198 metabolites in 283 serum samples from the human cohort KORA (Cooperative Health Research in the Region of Augsburg). Multivariate analysis of metabolic profiles revealed that the group of smokers could be clearly differentiated from the groups of former smokers and non-smokers. Moreover, 23 lipid metabolites were identified as nicotine-dependent biomarkers. The levels of these biomarkers are all up-regulated in smokers compared to those in former and non-smokers, except for three acyl-alkyl-phosphatidylcholines (e.g. plasmalogens). Consistently significant results were further found for the ratios of plasmalogens to diacyl-phosphatidylcolines, which are reduced in smokers and regulated by the enzyme alkylglycerone phosphate synthase (alkyl-DHAP) in both ether lipid and glycerophospholipid pathways. Notably, our metabolite profiles are consistent with the strong down-regulation of the gene for alkyl-DHAP (AGPS) in smokers that has been found in a study analyzing gene expression in human lung tissues. Our data suggest that smoking is associated with plasmalogen-deficiency disorders, caused by reduced or lack of activity of the peroxisomal enzyme alkyl-DHAP. Our findings provide new insight into the pathophysiology of smoking addiction. Activation of the enzyme alkyl-DHAP by small molecules may provide novel routes for therapy.

AB - Exposure to nicotine during smoking causes a multitude of metabolic changes that are poorly understood. We quantified and analyzed 198 metabolites in 283 serum samples from the human cohort KORA (Cooperative Health Research in the Region of Augsburg). Multivariate analysis of metabolic profiles revealed that the group of smokers could be clearly differentiated from the groups of former smokers and non-smokers. Moreover, 23 lipid metabolites were identified as nicotine-dependent biomarkers. The levels of these biomarkers are all up-regulated in smokers compared to those in former and non-smokers, except for three acyl-alkyl-phosphatidylcholines (e.g. plasmalogens). Consistently significant results were further found for the ratios of plasmalogens to diacyl-phosphatidylcolines, which are reduced in smokers and regulated by the enzyme alkylglycerone phosphate synthase (alkyl-DHAP) in both ether lipid and glycerophospholipid pathways. Notably, our metabolite profiles are consistent with the strong down-regulation of the gene for alkyl-DHAP (AGPS) in smokers that has been found in a study analyzing gene expression in human lung tissues. Our data suggest that smoking is associated with plasmalogen-deficiency disorders, caused by reduced or lack of activity of the peroxisomal enzyme alkyl-DHAP. Our findings provide new insight into the pathophysiology of smoking addiction. Activation of the enzyme alkyl-DHAP by small molecules may provide novel routes for therapy.

UR - http://www.scopus.com/inward/record.url?scp=57649167545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649167545&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0003863

DO - 10.1371/journal.pone.0003863

M3 - Article

VL - 3

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 12

M1 - e3863

ER -